A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide

FEBS Lett. 1999 Jan 8;442(1):112-6. doi: 10.1016/s0014-5793(98)01630-5.

Abstract

Studies have shown that beta defensins are present in the human airways and may be relevant to the pathogenesis of cystic fibrosis lung disease. Here we report the identification of a novel mouse gene, Defb2, which shows sequence similarity to previously described mouse and human airway beta defensins. Defb2 does not appear to be expressed in the airways of untreated mice but it is upregulated in response to lipopolysaccharide. The induced expression of this gene by an inflammatory stimulus strongly suggests that this defensin contributes to host defence at the mucosal surface of the airways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antimicrobial Cationic Peptides*
  • Base Sequence
  • DNA Primers / genetics
  • DNA, Complementary / genetics
  • Defensins
  • Female
  • Humans
  • Lipopolysaccharides / pharmacology*
  • Mice
  • Molecular Sequence Data
  • Peptides / genetics*
  • Proteins / genetics*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Respiratory System / drug effects*
  • Respiratory System / metabolism*
  • Sequence Homology, Amino Acid
  • Sequence Homology, Nucleic Acid
  • Tissue Distribution
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation / drug effects
  • beta-Defensins*

Substances

  • Antimicrobial Cationic Peptides
  • DNA Primers
  • DNA, Complementary
  • Defb2 protein, mouse
  • Defensins
  • Lipopolysaccharides
  • Peptides
  • Proteins
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • beta-Defensins

Associated data

  • GENBANK/AJ011800